33 related articles for article (PubMed ID: 16821593)
1. Nuclear medicine imaging of neuroendocrine tumours.
Al-Nahhas A
Clin Med (Lond); 2012 Aug; 12(4):377-80. PubMed ID: 22930887
[No Abstract] [Full Text] [Related]
2. Neuroendocrine differentiation in castration-resistant prostate cancer: A case report.
Priftakis D; Kritikos N; Stavrinides S; Kleanthous S; Baziotis N
Mol Clin Oncol; 2015 Nov; 3(6):1392-1394. PubMed ID: 26807253
[TBL] [Abstract][Full Text] [Related]
3. Octreotide in combination with AT-101 induces cytotoxicity and apoptosis through up-regulation of somatostatin receptors 2 and 5 in DU-145 prostate cancer cells.
Degirmenci M; Erdogan AP; Bulut G; Atmaca H; Uzunoglu S; Karaca B; Karabulut B; Uslu R
Tumour Biol; 2016 Apr; 37(4):4939-44. PubMed ID: 26531719
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer.
Mazzucchelli R; Morichetti D; Santinelli A; Scarpelli M; Bono AV; Lopez-Beltran A; Cheng L; Montironi R
Cell Oncol (Dordr); 2011 Jun; 34(3):235-43. PubMed ID: 21533650
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor subtypes in hormone-refractory (castration-resistant) prostatic carcinoma.
Mazzucchelli R; Morichetti D; Scarpelli M; Bono AV; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
Asian J Androl; 2011 Mar; 13(2):242-7. PubMed ID: 21151154
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin and the concept of peptide receptor scintigraphy in oncology.
Lamberts SW; Reubi JC; Krenning EP
Semin Oncol; 1994 Oct; 21(5 Suppl 13):1-5. PubMed ID: 7992074
[No Abstract] [Full Text] [Related]
7. Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy.
Nilsson S; Reubi JC; Kalkner KM; Laissue JA; Horisberger U; Olerud C; Westlin JE
Cancer Res; 1995 Dec; 55(23 Suppl):5805s-5810s. PubMed ID: 7493350
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide.
Breeman WA; van Hagen PM; Kwekkeboom DJ; Visser TJ; Krenning EP
Eur J Nucl Med; 1998 Feb; 25(2):182-6. PubMed ID: 9473268
[TBL] [Abstract][Full Text] [Related]
9. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
[TBL] [Abstract][Full Text] [Related]
10. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
Lebtahi R; Cadiot G; Delahaye N; Genin R; Daou D; Peker MC; Chosidow D; Faraggi M; Mignon M; Le Guludec D
J Nucl Med; 1999 Oct; 40(10):1602-8. PubMed ID: 10520698
[TBL] [Abstract][Full Text] [Related]
11. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
12. Effect of chemotherapy on somatostatin receptor detection with octreotide scintigraphy in hormone-refractory prostate cancer patients.
Mencobonii M; Tredici S; Rebella L; Bergaglio M; Galbusera V; Manzara A; Claudiani F; Malcangi B; Varaldo M
Anticancer Res; 2006; 26(3B):2233-5. PubMed ID: 16821593
[TBL] [Abstract][Full Text] [Related]
13. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
Krenning EP; Kwekkeboom DJ; de Jong M; Visser TJ; Reubi JC; Bakker WH; Kooij PP; Lamberts SW
Semin Oncol; 1994 Oct; 21(5 Suppl 13):6-14. PubMed ID: 7992084
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
